Emeritus Research is proud to be running clinical trials to investigate whether new medicines can improve Ulcerative Colitis for patients. Emeritus has been working with global pharmaceutical companies for the last 25 years and has been part of research that developed many of today’s leading medicines.
Coronavirus safety: Emeritus is lucky to have a dedicated clinical trials site that will not be seeing any patients with coronavirus symptoms. Further, all patients on arrival receive hospital grade hand sanitiser and are escorted to a private consulting room for their visits – no waiting rooms. We want to ensure that our patients can confidently be treated for their important chronic diseases in this challenging time.
Our past research was recently recognised by Channel 9 News: https://www.youtube.com/watch?v=8zyncxOthso
Benefits of being involved include:
- Access to leading Gastroenterologists running our Ulcerative Colitis studies and seeing participants.
- No costs for the visits or medications.
- Payment for your travel costs and inconvenience.
- Dedicated trial coordinator who will work with you throughout the study.